Sign in

CIK 0001528172 · Non-accelerated filer<br>Smaller reporting company

ENDONOVO THERAPEUTICS, INC.

Sign in to watch
Ticker
ENDV
Exchange
OTC
Industry
Electromedical & Electrotherapeutic Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
452552528
Phone
(800) 489-4774
Business address
6320 CANOGA AVENUE, 15TH FLOOR, WOODLAND HILLS, CA, 91367
Former names
Hanover Portfolio Acquisitions, Inc.
  1. 4 Open-market buy President bought 8,000 shares at an average $0.06 ($471)
  2. 4 Open-market buy President bought 23,000 shares at an average $0.06 ($1,320)
  3. 4 Open-market buy President bought 6,000 shares at an average $0.06 ($346)
  4. 4 Open-market buy President bought 29,200 shares at an average $0.05 ($1,451)
  5. 4 Open-market buy President bought 15,800 shares at an average $0.02 ($251)
  6. 4 Open-market buy President bought 14,300 shares at an average $0.01 ($181)
  7. 4 Open-market buy President bought 20,100 shares at an average $0.01 ($278)
  8. 4 Open-market buy President bought 25,100 shares at an average $0.02 ($598)
  9. 4 Open-market buy President bought 16,900 shares at an average $0.03 ($559)
  10. 4 Open-market buy President bought 30,400 shares at an average $0.03 ($1,018)
  11. 4 Open-market buy President bought 19,200 shares at an average $0.05 ($932)
  12. 4 Open-market buy President bought 12,934 shares at an average $0.04 ($553)
  13. 4 Open-market buy President bought 7,800 shares at an average $0.05 ($396)
  14. 4 Open-market buy President bought 8,600 shares at an average $0.05 ($452)
  15. 4 Open-market buy President bought 200 shares at $0.06 ($12)
  16. 4 Open-market buy president bought 23,700 shares at an average $5.12 ($121,283)
  17. 3 Insider Initial Statement of Ownership
  18. 8-K Event Shareholder rights changed
  19. 8-K Event Shareholder rights changed
  20. UPLOAD Other SEC-generated Letter

Page 20 of 26 · 502 filings